{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T05:06:36Z","timestamp":1738818396549,"version":"3.37.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Aravind Eye Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11033-024-09903-w","type":"journal-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T15:03:19Z","timestamp":1725894199000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigating the frequency of somatic MYD88 L265P mutation in primary ocular adnexal B cell lymphoma"],"prefix":"10.1007","volume":"51","author":[{"given":"Karuvel Kannan","family":"Saraswathi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radhakrishnan","family":"Santhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usha","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayyasamy","family":"Vanniarajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,9]]},"reference":[{"key":"9903_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/978-3-642-38499-8_2","volume-title":"Ocular and Adnexal Lymphoma","author":"SE Coupland","year":"2014","unstructured":"Coupland SE (2014) Ocular and Adnexal Lymphoma: Histopathology. In: Singh AD (ed) Ocular and Adnexal Lymphoma. Berlin Heidelberg, Springer, Berlin, Heidelberg, pp 11\u201323"},{"issue":"1","key":"9903_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.survophthal.2018.08.002","volume":"64","author":"TG Olsen","year":"2019","unstructured":"Olsen TG, Heegaard S (2019) Orbital lymphoma. Surv Ophthalmol 64(1):45\u201366. https:\/\/doi.org\/10.1016\/j.survophthal.2018.08.002","journal-title":"Surv Ophthalmol"},{"issue":"11","key":"9903_CR3","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1158\/1078-0432.Ccr-15-1525","volume":"22","author":"J Rovira","year":"2016","unstructured":"Rovira J, Karube K, Valera A, Colomer D, Enjuanes A, Colomo L et al (2016) MYD88 L265P mutations, but no other variants, identify a subpopulation of DLBCL patients of activated B-cell origin, extranodal involvement, and poor outcome. Clin Cancer Res 22(11):2755\u20132764. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-15-1525","journal-title":"Clin Cancer Res"},{"issue":"1","key":"9903_CR4","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41408-023-00896-6","volume":"13","author":"M Minderman","year":"2023","unstructured":"Minderman M, Lantermans H, van der Zwaan C, Hoogendijk AJ, van den Biggelaar M, Kersten MJ et al (2023) The oncogenic human B-cell lymphoma MYD88 L265P mutation genocopies activation by phosphorylation at the Toll\/interleukin-1 receptor (TIR) domain. Blood Cancer J 13(1):125. https:\/\/doi.org\/10.1038\/s41408-023-00896-6","journal-title":"Blood Cancer J"},{"issue":"9","key":"9903_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2013.28","volume":"3","author":"W Kraan","year":"2013","unstructured":"Kraan W, Horlings HM, van Keimpema M, Schilder-Tol EJ, Oud ME, Scheepstra C et al (2013) High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites. Blood Cancer J 3(9):e139. https:\/\/doi.org\/10.1038\/bcj.2013.28","journal-title":"Blood Cancer J"},{"issue":"3","key":"9903_CR6","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.hemonc.2020.10.003","volume":"14","author":"R Shekhar","year":"2021","unstructured":"Shekhar R, Naseem S, Binota J, Varma N, Malhotra P (2021) Frequency of MYD88 L256P mutation and its correlation with clinico-hematological profile in mature B-cell neoplasm. Hematol Oncol Stem Cell Ther 14(3):231\u2013239. https:\/\/doi.org\/10.1016\/j.hemonc.2020.10.003","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"10","key":"9903_CR7","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1158\/0008-5472.CAN-18-0215","volume":"78","author":"X Yu","year":"2018","unstructured":"Yu X, Li W, Deng Q, Li L, Hsi ED, Young KH et al (2018) MYD88 L265P mutation in lymphoid malignancies. Cancer Res 78(10):2457\u20132462. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-0215","journal-title":"Cancer Res"},{"issue":"11","key":"9903_CR8","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1001\/jamadermatol.2014.821","volume":"150","author":"A Pham-Ledard","year":"2014","unstructured":"Pham-Ledard A, Beylot-Barry M, Barbe C, Leduc M, Petrella T, Vergier B et al (2014) High frequency and clinical prognostic value of MYD88 L265P mutation in primary cutaneous diffuse large B-cell lymphoma, leg-type. JAMA Dermatol 150(11):1173\u20131179. https:\/\/doi.org\/10.1001\/jamadermatol.2014.821","journal-title":"JAMA Dermatol"},{"issue":"3","key":"9903_CR9","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/s41375-023-02120-7","volume":"38","author":"W Ren","year":"2024","unstructured":"Ren W, Wan H, Own SA, Berglund M, Wang X, Yang M et al (2024) Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis. Leukemia 38(3):610\u2013620. https:\/\/doi.org\/10.1038\/s41375-023-02120-7","journal-title":"Leukemia"},{"issue":"11","key":"9903_CR10","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1007\/s00262-018-2242-9","volume":"67","author":"ANR Weber","year":"2018","unstructured":"Weber ANR, Cardona Gloria Y, \u00c7\u0131nar \u00d6, Reinhardt HC, Pezzutto A, Wolz OO (2018) Oncogenic MYD88 mutations in lymphoma: novel insights and therapeutic possibilities. Cancer Immunol Immunother 67(11):1797\u20131807. https:\/\/doi.org\/10.1007\/s00262-018-2242-9","journal-title":"Cancer Immunol Immunother"},{"issue":"9","key":"9903_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0221941","volume":"14","author":"A Nakamura","year":"2019","unstructured":"Nakamura A, Ohwada C, Takeuchi M, Takeda Y, Tsukamoto S, Mimura N et al (2019) Detection of MYD88 L265P mutation by next-generation deep sequencing in peripheral blood mononuclear cells of Waldenstr\u00f6m\u2019s macroglobulinemia and IgM monoclonal gammopathy of undetermined significance. PLoS ONE 14(9):e0221941. https:\/\/doi.org\/10.1371\/journal.pone.0221941","journal-title":"PLoS ONE"},{"issue":"3","key":"9903_CR12","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/hon.2718","volume":"38","author":"V Vela","year":"2020","unstructured":"Vela V, Juskevicius D, Gerlach MM, Meyer P, Graber A, Cathomas G et al (2020) High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B-cell lymphomas. Hematol Oncol 38(3):284\u2013292. https:\/\/doi.org\/10.1002\/hon.2718","journal-title":"Hematol Oncol"},{"key":"9903_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.817635","volume":"12","author":"A Zhao","year":"2022","unstructured":"Zhao A, Wu F, Wang Y, Li J, Xu W, Liu H (2022) Analysis of genetic alterations in ocular adnexal mucosa-associated lymphoid tissue lymphoma with whole-exome sequencing. Front Oncol 12:817635. https:\/\/doi.org\/10.3389\/fonc.2022.817635","journal-title":"Front Oncol"},{"issue":"4","key":"9903_CR14","doi-asserted-by":"publisher","first-page":"483","DOI":"10.5858\/arpa.2018-0092-OA","volume":"143","author":"A Behdad","year":"2019","unstructured":"Behdad A, Zhou XY, Gao J, Raparia K, Dittman D, Green SJ et al (2019) High frequency of MYD88 L265P mutation in primary ocular adnexal marginal zone lymphoma and its clinicopathologic correlation: a study from a single institution. Arch Pathol Lab Med 143(4):483\u2013493. https:\/\/doi.org\/10.5858\/arpa.2018-0092-OA","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"9903_CR15","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1136\/bjophthalmol-2021-319580","volume":"107","author":"MK Kirkegaard","year":"2023","unstructured":"Kirkegaard MK, Minderman M, Sjo LD, Pals ST, Eriksen PRG, Heegaard S (2023) Prevalence and prognostic value of MYD88 and CD79B mutations in ocular adnexal large B-cell lymphoma: a reclassification of ocular adnexal large B-cell lymphoma. Br J Ophthalmol 107(4):576\u2013581. https:\/\/doi.org\/10.1136\/bjophthalmol-2021-319580","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"9903_CR16","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/modpathol.2016.79","volume":"29","author":"AK Cani","year":"2016","unstructured":"Cani AK, Soliman M, Hovelson DH, Liu CJ, McDaniel AS, Haller MJ et al (2016) Comprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapies. Mod Pathol 29(7):685\u2013697. https:\/\/doi.org\/10.1038\/modpathol.2016.79","journal-title":"Mod Pathol"},{"issue":"12","key":"9903_CR17","doi-asserted-by":"publisher","first-page":"e558","DOI":"10.3324\/haematol.2018.214957","volume":"104","author":"L Cascione","year":"2019","unstructured":"Cascione L, Rinaldi A, Bruscaggin A, Tarantelli C, Arribas AJ, Kwee I et al (2019) Novel insights into the genetics and epigenetics of MALT lymphoma unveiled by next generation sequencing analyses. Haematologica 104(12):e558\u2013e561. https:\/\/doi.org\/10.3324\/haematol.2018.214957","journal-title":"Haematologica"},{"issue":"2","key":"9903_CR18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00428-021-03186-3","volume":"480","author":"V Vela","year":"2022","unstructured":"Vela V, Juskevicius D, Dirnhofer S, Menter T, Tzankov A (2022) Mutational landscape of marginal zone B-cell lymphomas of various origin: organotypic alterations and diagnostic potential for assignment of organ origin. Virchows Arch 480(2):403\u2013413. https:\/\/doi.org\/10.1007\/s00428-021-03186-3","journal-title":"Virchows Arch"},{"issue":"5","key":"9903_CR19","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/j.1365-2141.2012.09176.x","volume":"158","author":"ZM Li","year":"2012","unstructured":"Li ZM, Rinaldi A, Cavalli A, Mensah AA, Ponzoni M, Gascoyne RD et al (2012) MYD88 somatic mutations in MALT lymphomas. Br J Haematol 158(5):662\u2013664. https:\/\/doi.org\/10.1111\/j.1365-2141.2012.09176.x","journal-title":"Br J Haematol"},{"issue":"8","key":"9903_CR20","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.3324\/haematol.2018.191601","volume":"103","author":"S Moody","year":"2018","unstructured":"Moody S, Thompson JS, Chuang SS, Liu H, Raderer M, Vassiliou G et al (2018) Novel GPR34 and CCR6 mutation and distinct genetic profiles in MALT lymphomas of different sites. Haematologica 103(8):1329\u20131336. https:\/\/doi.org\/10.3324\/haematol.2018.191601","journal-title":"Haematologica"},{"issue":"6","key":"9903_CR21","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/bjh.12162","volume":"160","author":"Q Yan","year":"2013","unstructured":"Yan Q, Wang M, Moody S, Xue X, Huang Y, Bi Y et al (2013) Distinct involvement of NF-\u03baB regulators by somatic mutation in ocular adnexal malt lymphoma. Br J Haematol 160(6):851\u2013854. https:\/\/doi.org\/10.1111\/bjh.12162","journal-title":"Br J Haematol"},{"issue":"1","key":"9903_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/path.4933","volume":"243","author":"S Moody","year":"2017","unstructured":"Moody S, Escudero-Ibarz L, Wang M, Clipson A, Ochoa Ruiz E, Dunn-Walters D et al (2017) Significant association between TNFAIP3 inactivation and biased immunoglobulin heavy chain variable region 4\u201334 usage in mucosa-associated lymphoid tissue lymphoma. J Pathol 243(1):3\u20138. https:\/\/doi.org\/10.1002\/path.4933","journal-title":"J Pathol"},{"issue":"9","key":"9903_CR23","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/ajh.23490","volume":"88","author":"D Zhu","year":"2013","unstructured":"Zhu D, Ikpatt OF, Dubovy SR, Lossos C, Natkunam Y, Chapman-Fredricks JR et al (2013) Molecular and genomic aberrations in Chlamydophila psittaci negative ocular adnexal marginal zone lymphomas. Am J Hematol 88(9):730\u2013735. https:\/\/doi.org\/10.1002\/ajh.23490","journal-title":"Am J Hematol"},{"issue":"1","key":"9903_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1158\/2767-9764.crc-21-0022","volume":"1","author":"M Magistri","year":"2021","unstructured":"Magistri M, Happ LE, Ramdial J, Lu X, Stathias V, Kunkalla K et al (2021) The genetic landscape of ocular adnexa MALT lymphoma reveals frequent aberrations in NFAT and MEF2B signaling pathways. Cancer Res Commun 1(1):1\u201316. https:\/\/doi.org\/10.1158\/2767-9764.crc-21-0022","journal-title":"Cancer Res Commun"},{"issue":"38","key":"9903_CR25","doi-asserted-by":"publisher","first-page":"62627","DOI":"10.18632\/oncotarget.11548","volume":"7","author":"P Johansson","year":"2016","unstructured":"Johansson P, Klein-Hitpass L, Grabellus F, Arnold G, Klapper W, Pf\u00f6rtner R et al (2016) Recurrent mutations in NF-\u03baB pathway components, KMT2D, and NOTCH1\/2 in ocular adnexal MALT-type marginal zone lymphomas. Oncotarget 7(38):62627\u201362639","journal-title":"Oncotarget"},{"key":"9903_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12040986","author":"P Johansson","year":"2020","unstructured":"Johansson P, Klein-Hitpass L, Budeus B, Kuhn M, Lauber C, Seifert M et al (2020) Identifying genetic lesions in ocular adnexal extranodal marginal zone lymphomas of the MALT subtype by whole genome, whole exome and targeted sequencing. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers12040986","journal-title":"Cancers (Basel)"},{"issue":"5","key":"9903_CR27","first-page":"436","volume":"5","author":"F Liu","year":"2012","unstructured":"Liu F, Karube K, Kato H, Arita K, Yoshida N, Yamamoto K et al (2012) Mutation analysis of NF-kappaB signal pathway-related genes in ocular MALT lymphoma. Int J Clin Exp Pathol 5(5):436\u2013441","journal-title":"Int J Clin Exp Pathol"},{"issue":"5","key":"9903_CR28","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1097\/PAS.0000000000000411","volume":"39","author":"A Martinez-Lopez","year":"2015","unstructured":"Martinez-Lopez A, Curiel-Olmo S, Mollejo M, Cereceda L, Martinez N, Montes-Moreno S et al (2015) MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma. Am J Surg Pathol 39(5):644\u2013651. https:\/\/doi.org\/10.1097\/PAS.0000000000000411","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"9903_CR29","doi-asserted-by":"publisher","first-page":"17038","DOI":"10.18632\/oncotarget.14928","volume":"8","author":"H Jung","year":"2017","unstructured":"Jung H, Yoo HY, Lee SH, Shin S, Kim SC, Lee S et al (2017) The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in TNFAIP3 followed by mutations in TBL1XR1 and CREBBP. Oncotarget 8(10):17038\u201317049","journal-title":"Oncotarget"},{"issue":"12","key":"9903_CR30","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1038\/s41375-018-0197-7","volume":"32","author":"T Bagratuni","year":"2018","unstructured":"Bagratuni T, Ntanasis-Stathopoulos I, Gavriatopoulou M, Mavrianou-Koutsoukou N, Liacos C, Patseas D et al (2018) Detection of MYD88 and CXCR4 mutations in cell-free DNA of patients with IgM monoclonal gammopathies. Leukemia 32(12):2617\u20132625. https:\/\/doi.org\/10.1038\/s41375-018-0197-7","journal-title":"Leukemia"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09903-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-024-09903-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09903-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T04:16:55Z","timestamp":1738729015000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-024-09903-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,9]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9903"],"URL":"https:\/\/doi.org\/10.1007\/s11033-024-09903-w","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2024,9,9]]},"assertion":[{"value":"2 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We declared that none of the authors has financial and personal competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"This work was done with approval from the Institutional Ethics Committee (IRB2018014BAS) and followed the tenets of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All tumor samples were collected with the informed consent from patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"973"}}